FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 332 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR ESMO Launches Clinical Trials Funding Initiative to Optimise Cancer Care Pathways September 10, 2026 Four randomized prospective degree compared 90 days regarding neoadjuvant ADT observed... July 21, 2023 Time to take on 9 new Cancer Grand Challenges March 8, 2023 Breast Cancer Patient Devotes Her Time to Driving Others to Treatment March 15, 2021 Load more HOT NEWS Prefrail and Frail Young Adult Survivors of Childhood Cancers Experience Significant... ΚΑΡΚΙΝΟΣ ΟΡΧΕΩΝ Cancer in My Community: Overcoming Delays in Care for Children With... Enfortumab Vedotin Approved for Recurrent Bladder Cancer
